Global Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called �antigens�). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C�sar Milstein and Georges K�hler � scientists at the Roche-funded Basel Institute for Immunology � who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
According to our (Global Info Research) latest study, the global Antibody market size was valued at USD 9354.2 million in 2022 and is forecast to a readjusted size of USD 13230 million by 2029 with a CAGR of 5.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent. 
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
This report is a detailed and comprehensive analysis for global Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibody market size and forecasts, in consumption value ($ Million), sales quantity (KG), and average selling prices (USD/KG), 2018-2029
Global Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (KG), and average selling prices (USD/KG), 2018-2029
Global Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (KG), and average selling prices (USD/KG), 2018-2029
Global Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (KG), and ASP (USD/KG), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Johnson and Johnson, Merck, Novartis and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    IgM
    IgG
    IgA
    Other
Market segment by Application
    Therapeutic
    Research
    Diagnostic
Major players covered
    Roche
    Johnson and Johnson
    Merck
    Novartis
    AbbVie
    Amgen
    Pfizer
    Bayer
    Lilly
    Bristol-Myers Squibb
    GlaxoSmithKline
    Biogen
    AstraZeneca
    Sanofi
    Alexion Pharmaceuticals
    Seattle Genetics
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antibody, with price, sales, revenue and global market share of Antibody from 2018 to 2023.
Chapter 3, the Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antibody.
Chapter 14 and 15, to describe Antibody sales channel, distributors, customers, research findings and conclusion.